Please login to the form below

Not currently logged in
Email:
Password:

cost-effectiveness

This page shows the latest cost-effectiveness news and features for those working in and with pharma, biotech and healthcare.

NICE backs first cannabis-based drugs, both from GW Pharma

NICE backs first cannabis-based drugs, both from GW Pharma

Updated guidelines from cost-effectiveness watchdog NICE back the use of GW Pharma’s Epidyolex (cannabidiol) for the treatment of seizures in patients with Lennox Gastaut syndrome (LGS) or Dravet syndrome –

Latest news

More from news
Approximately 3 fully matching, plus 558 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 61 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 22 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics